|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
44, Rue des Berges, Grenoble, Auvergne-Rhône-Alpes 38000, FR
|
|
Fluoptics is a young and innovative company in the field of fluorescence imaging for both clinical and preclinical applications. In clinics, Fluoptics develops solutions to optically guide cancer surgery. This approach is based on an intra-operative near infra-red fluorescence detector and fluorescent probes which specifically target tumors. This technology, extensively tested on animals, drastically improves cancer surgery in providing surgeons with an acute delineation of cancerous nodules during the surgery.
Fluoptics develops and markets the Fluobeam, a unique fluorescence imaging system with an open design and an excellent sensitivity in the near infra-red spectrum. The company also proposes near infra-red molecular probes AngioStampTM for tumors and angiogenesis, and SentiDyeTM for vascular networks and lymphatic drainage. The instrument, as well as the probes, helps in understanding disease mechanisms and in developing new therapies.
|
FLUOPTICS Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used FLUOPTICS email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact FLUOPTICS customer service number in your country click here to find.
Odile Allard is the CEO of FLUOPTICS. To contact Odile Allard email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.